Home | Medical-Newswire.Com:
(Medical-NewsWire.com, June 19, 2017 ) Browse 151 market data tables and 40 figures spread through 266 pages and in-depth TOC on “Proteomics Market”
Early buyers will receive 10% customization on this report.
The global market exhibits potential for significant growth and is propelled by the increasing need for personalized medicine, R&D expenditure, technological advancements, and increased funding for proteomics projects.
However, a few pivotal factors hampering the growth of this market include the reduced funds in key markets, sequestration cuts in the U.S. and reduced funds for proteomics research, high cost of tools and equipment, and dearth of skilled researchers.
Download PDF Brochure@
In this report, the global proteomics market is majorly segmented on the basis of instrumentation technology, application, reagent, services & software, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global market and its submarkets. On the basis of regent, the protein fractionation reagents segment is projected to register the highest CAGR during the forecast period.
The high growth in this segment is attributed to the benefits of protein fractionation such as high resolution, and effectively separate thousands of proteins in a complex structure. On the basis of services and software, the analytical laboratory services segment commanded for the largest share of the market as these services help in effective diagnosis and research for drug discovery.
Request For Customization Of This Report:
On the basis of application, the proteomics market is segmented into drug discovery, clinical diagnostics, and other applications. The clinical diagnostics segment accounted for the largest share of the global market in 2015. This is attributed to the increased understanding of the relevance of investigating and understanding patterns of protein expression for diseases and drug development.
In this report, the global market has been studied at the regional and country levels. In 2015, North America represented the largest regional market, followed by Europe. The Asia-Pacific region is expected to register the highest CAGR during the forecast period. The growth of this regional segment is driven by the significant economic development in emerging markets, proteomics technologies playing an integral role in the modern pharmaceutical and healthcare industries, and rising focus of key market players on this region.
The major players in the global proteomics market are Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Luminex Corporation (U.S.), Merck KGaA (Germany), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States